Skip to menu Skip to content Skip to footer

A randomised, placebo-controlled trial of Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia in chronic kidney disease (2011-2015)

Experts

Professor David Johnson

NHMRC Leadership Fellow
Centre for Health Services Research
Faculty of Health, Medicine and Behavioural Sciences
David Johnson
David Johnson

Professor Robert Fassett

Affiliate of Centre for Research on Exercise, Physical Activity and Health
Centre for Research on Exercise, Physical Activity and Health
Faculty of Health, Medicine and Behavioural Sciences
ATH - Professor
Royal Brisbane Clinical Unit
Faculty of Health, Medicine and Behavioural Sciences
Robert Fassett